University of California, San Francisco
Dr. Ava Xu, PharmD, is currently studying to get her PhD degree in the Pharmacogenomics and Pharmaceutical Sciences program at University of California, San Francisco. She earned her PharmD from the Chapman University, and currently is studying on the topic of Tuberculosis pharmacogenomics. She is interested in developing methodology that incorporates pharmacogenomics data to better predict population pharmacokinetic/pharmacodynamic model parameters. Ultimately, her goal is to use such models to provide personalized recommendations for patients and to guide clinical trial designs.